View Author
patient treatment hepatitis resistance therapy response hepatitis b study baseline hepatology ef ficacy level month hbv dna entecavir cirrhosis monotherapy hbeag etv monotherapy virological virus combination hbv dna levels liver probability mutation virological response disease analysis ficacy combination therapy genotypic follow-up tenofovir virologic response lamivudine hepatitis b virus virologic adefovir genotypic resistance serum table na-na tdf monotherapy liver disease range tdf treatment signi disease progression department hbsag event breakthrough baseline hbv dna model hepatitis b patients effect group lam resistance adv resistance na-na ıve patients germany virological breakthrough rescue therapy na-experienced presence progression gastroenterology history week 48 hbeag status hepatology 2010 vol result virologic breakthrough lam-resistance population cohort hbeag-positive lam-resistant mutations decompensated
5 Most Recent Publications
|
Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis
(Article)
Zoutendijk, R. Reijnders, J.G.P. Berg, T. Hansen, B.E. Sonneveld, M.J. Wedemeyer, H. Janssen, H.L.A. Zoulim, F. Brown, A. Mutimer, D.J. Deterding, K. Hofmann, W.P. Petersen, J. Fasano, M. Buti, M. |
2013-05-01
|
|
Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: An international multicenter cohort study
(Article)
Petersen, J. Ratziu, V. Berg, T. Sarrazin, C. Lutgehetmann, M. Buggisch, P. Buti, M. Janssen, H.L.A. Brown, A. Lampertico, P. Schollmeyer, J. Zoulim, F. Wedemeyer, H. Sterneck, M. |
2012-03-01
|
|
Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response
(Article)
Zoutendijk, R. Reijnders, J.G.P. Bömmel, F. van Pradat, P. Oo, Y. Luetgehetmann, M. Berg, T. Hansen, B.E. Wedemeyer, H. Janssen, H.L.A. Brown, A. Zoulim, F. Mutimer, D. Deterding, K. Petersen, J. Hofmann, W.P. Buti, M. Santantonio, T. |
2011-08-01
|
|
Antiviral effect of entecavir in chronic hepatitis B: Influence of prior exposure to nucleos(t)ide analogues
(Article)
Reijnders, J.G.P. Deterding, K. Petersen, J. Zoulim, F. Santantonio, T. Buti, M. Bömmel, F. van Hansen, B.E. Wedemeyer, H. Janssen, H.L.A. |
2010-04-01
|
|
Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues
(Article)
Bömmel, F. van Man, R.A. de Sarrazin, C. Böcher, W.O. Spengler, U. Wasmuth, H.E. Reinders, J.G.P. Möller, B. Rhode, P. Feucht, H.H. Wiedenmann, B. Berg, T. Wedemeyer, H. Deterding, K. Petersen, J. Buggisch, P. Erhardt, A. Hüppe, D. Stein, K. Trojan, J. |
2010-01-01
|
